Last reviewed · How we verify
Analgesia at home — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Analgesia at home (Analgesia at home) — Universidade do Porto.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Analgesia at home TARGET | Analgesia at home | Universidade do Porto | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Analgesia at home CI watch — RSS
- Analgesia at home CI watch — Atom
- Analgesia at home CI watch — JSON
- Analgesia at home alone — RSS
Cite this brief
Drug Landscape (2026). Analgesia at home — Competitive Intelligence Brief. https://druglandscape.com/ci/analgesia-at-home. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab